Table 3. Follow-up outcome of patients.

Patient number	Degree of dysphagia before stenting/after stenting	KPS before stenting/after stenting	Stent-related complications	Survival (days)	Tumor-specific therapy after stenting
1	4/3	60/80	Granulation	318	Gastrostomy, SEMS placement and replacement, chemotherapy, and radiotherapy
2	3/2	60/80	Retrosternal pain, sputum retention	575	Chemotherapy, Y silicone stent replacement
3	4/3	60/80	NA	389	Chemotherapy, radiotherapy, immunotherapy, and targeted therapy
4	4/3	50/70	Retrosternal pain	237	Gastrostomy, Y silicone stent replacement, radiotherapy, and chemotherapy
5	4/3	60/80	Granulation, sputum retention	602	Jejunostomy, radiotherapy, and chemotherapy
6	4/2	50/70	Sputum retention	154	SEMS placement, radiotherapy, and chemotherapy
7	4/1	60/80	Granulation, sputum retention	392	Y silicone stent replacement, SEMS placement, laser resection, balloon dilation, radiotherapy, chemotherapy, and immunotherapy
8	4/4	50/20	Sputum retention	19	Jejunostomy
9	4/2	50/70	Fistula occurrence	147	Targeted therapy
10	4/4	50/30	Sputum retention	75	Chemotherapy, immunotherapy, and jejunostomy

KPS, Karnofsky Performance Status; SEMS, self-expandable metal stent; NA, not available.